ArticleAnnals of pediatric cardiology2011
Global research priorities in rheumatic fever and rheumatic heart disease.
Article in Annals of pediatric cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.
- Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.Nature reviews. Cardiology · 2013Guideline
- Gaps, Obstacles, and Opportunities in Rheumatic Heart Disease Research: Where Are We Now?JACC. Advances · 2023Article
- The Impact of a Handheld Ultrasound Device in a Rheumatic Heart Disease Screening Program in Ethiopia.POCUS journal · 2023Article
- Article
- Article
- Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.Pathogens (Basel, Switzerland) · 2022Review
- Generating Global Priority for Addressing Rheumatic Heart Disease: A Qualitative Policy Analysis.Journal of the American Heart Association · 2020Review
- Rheumatic Heart Disease Patients' Adherence to Secondary Prophylaxis and Associated Factors at Hospitals in Jimma Zone, Southwest Ethiopia: A Multicenter Study.Patient preference and adherence · 2020Article
- Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand.International journal of environmental research and public health · 2019Review
- Use of broad consent and related procedures in genomics research: Perspectives from research participants in the Genetics of Rheumatic Heart Disease (RHDGen) study in a University Teaching Hospital in Zambia.Global bioethics = Problemi di bioetica · 2019Article
- Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania.Nature communications · 2017Article
- Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost-Utility Analysis.Journal of the American Heart Association · 2017Article
- A novel approach for characterizing variations in serum peptides in rheumatic heart disease.The Indian journal of medical research · 2017Article
- RF and RHD Research.Global heart · 2017Review
- "I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa.BMC medical ethics · 2017Article
- Acute rheumatic fever outbreak in southern central European country.European journal of pediatrics · 2017Article
- Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.Drug delivery and translational research · 2016Article
- Echocardiographic screening for rheumatic heart disease-some answers, but questions remain.Translational pediatrics · 2015Article
- The case for global investment in rheumatic heart-disease control.Bulletin of the World Health Organization · 2014Article
- Incidence, prevalence and outcomes of rheumatic heart disease in South Africa: a systematic review protocol.BMJ open · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
We now stand at a critical juncture for rheumatic fever (RF) and rheumatic heart disease (RHD) control. In recent years, we have seen a surge of interest in these diseases in regions of the world where RF/RHD mostly occur. This brings real opportunities to make dramatic progress in the next few years, but also real risks if we miss these opportunities. Most public health and clinical approaches in RF/RHD arose directly from programmes of research. Many unanswered questions remain, including those around how to implement what we know will work, so research will continue to be essential in our efforts to bring a global solution to this disease. Here we outline our proposed research priorities in RF/RHD for the coming decade, grouped under the following four challenges: Translating what we know already into practical RHD control; How to identify people with RHD earlier, so that preventive measures have a higher chance of success; Better understanding of disease pathogenesis, with a view to improved diagnosis and treatment of ARF and RHD; and Finding an effective approach to primary prevention. We propose a mixture of basic, applied, and implementation science. With concerted efforts, strong links to clinical and public health infrastructure, and advocacy and funding support from the international community, there are good prospects for controlling these RF and RHD over the next decade.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.